First Mercantile Trust’s Bristol-Myers Squibb BMY Stock Holding History

First Mercantile Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,440	Closed	-$261K	–	849
2020 Q2	$261K	Sell	4,440 -2,970	-40%	-$178K	0.03%	300
2020 Q1	$413K	Sell	7,410 -1,270	-15%	-$77.6K	0.06%	187
2019 Q4	$557K	Sell	8,680 -3,512	-29%	-$201K	0.06%	205
2019 Q3	$619K	Sell	12,192 -4	-0%	-$188	0.07%	195
2019 Q2	$553K	Sell	12,196 -3,239	-21%	-$151K	0.06%	193
2019 Q1	$737K	Sell	15,435 -59,910	-80%	-$2.98M	0.17%	140
2018 Q4	$3.92M	Sell	75,345 -482	-0.6%	-$25.9K	0.95%	11
2018 Q3	$4.71M	Buy	75,827 +6,909	+10%	+$410K	0.93%	12
2018 Q2	$3.81M	Buy	68,918 +6,063	+10%	+$327K	0.76%	19
2018 Q1	$3.98M	Buy	62,855 +62,365	+12,728%	+$4.01M	0.83%	17
2017 Q4	$30K	Sell	490 -4,785	-91%	-$299K	0.01%	798
2017 Q3	$336K	Sell	5,275 -224	-4%	-$13.1K	0.06%	403
2017 Q2	$306K	Sell	5,499 -552	-9%	-$30K	0.06%	437
2017 Q1	$329K	Sell	6,051 -361	-6%	-$19.8K	0.05%	456
2016 Q4	$375K	Sell	6,412 -1,379	-18%	-$75.4K	0.06%	432
2016 Q3	$420K	Sell	7,791 -1,074	-12%	-$69K	0.06%	414
2016 Q2	$652K	Sell	8,865 -1,508	-15%	-$107K	0.08%	330
2016 Q1	$663K	Sell	10,373 -888	-8%	-$56K	0.08%	311
2015 Q4	$775K	Buy	11,261 +114	+1%	+$7.53K	0.08%	311
2015 Q3	$660K	Buy	11,147 +2,035	+22%	+$129K	0.07%	361
2015 Q2	$606K	Buy	9,112 +115	+1%	+$7.58K	0.05%	442
2015 Q1	$580K	Sell	8,997 -731	-8%	-$45.8K	0.05%	450
2014 Q4	$574K	Buy	9,728 +1,405	+17%	+$79.2K	0.05%	461
2014 Q3	$426K	Buy	8,323 +762	+10%	+$38.1K	0.03%	570
2014 Q2	$367K	Buy	7,561 +302	+4%	+$14.9K	0.03%	593
2014 Q1	$377K	Buy	7,259 +6,514	+874%	+$347K	0.03%	669
2013 Q4	$40K	Sell	745 -16	-2%	-$815	﹤0.01%	1024
2013 Q3	$35K	Buy	761 +31	+4%	+$1.36K	﹤0.01%	1034
2013 Q2	$33K	Buy	+730	New	+$31.7K	﹤0.01%	1035

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

First Mercantile Trust's BMY Position: Q3 2020 in Review

First Mercantile Trust sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 4,440 shares — an estimated $261K sold.

First Mercantile Trust first reported a position in BMY in Q2 2013 and held it in 29 quarters. The position peaked at $4.71M in Q3 2018. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

First Mercantile Trust reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
First Mercantile Trust sold 4,440 Bristol-Myers Squibb shares in Q3 2020, an estimated $261K.
First Mercantile Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 29 quarters.
First Mercantile Trust's Bristol-Myers Squibb position peaked at $4.71M in Q3 2018.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on First Mercantile Trust's 13F filing for Q3 2020, filed 12 Nov 2020.